• Targeted Amikacin Delivery via Dendritic Cells in Granulomas

  2026-05-20

  This study demonstrates the feasibility of using dendritic cells as cellular vehicles for localized delivery of Amikacin into granulomas in Mycobacterium avium-infected mice. The approach offers a promising strategy to enhance antibiotic efficacy against non-tuberculous mycobacterial infections while minimizing systemic toxicity and resistance development.

• RNA Pol II Inhibition Triggers Apoptosis Independently of Tr

  2026-05-20

  Harper et al. (2025) reveal that cell death following RNA polymerase II inhibition is not due to passive mRNA decay, but is instead a regulated, apoptosis-driven response initiated by the loss of hypophosphorylated RNA Pol IIA. These insights reshape our understanding of cell death mechanisms in cancer research and suggest new avenues for targeting apoptosis pathways.

• Tamoxifen in Breast Cancer Research: Mechanisms, Innovations

  2026-05-19

  Explore the multifaceted role of Tamoxifen as a selective estrogen receptor modulator in breast cancer research, with a deep dive into its mechanistic innovations and advanced uses in gene knockout models. This article provides unique assay insights and bridges recent findings on caveolin-1 modulation.

• ML-7 Hydrochloride (SKU A3626): Reliable MLCK Inhibition in

  2026-05-19

  This article explores how ML-7 hydrochloride (SKU A3626) delivers robust, reproducible solutions for cell viability, proliferation, and cytotoxicity assays. Drawing on validated experimental scenarios and peer-reviewed evidence, we highlight its selectivity, protocol flexibility, and supplier reliability for advanced biomedical workflows.

• Aprotinin: Applied Workflows and Troubleshooting in Protease

  2026-05-18

  Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI) empowers researchers to precisely control serine protease activity in assays spanning cardiovascular blood management to high-throughput transcriptomics. This guide delivers actionable protocols, real-world troubleshooting, and key innovations validated by current literature, ensuring optimal performance in both complex and routine experimental systems.

• EdU Imaging Kits (HF594): Precision S-Phase Analysis in Treg

  2026-05-18

  Explore how EdU Imaging Kits (HF594) enable advanced, high-fidelity DNA synthesis measurement in S-phase cells. This article delivers a unique, mechanistic perspective on Treg cell differentiation and asthma pathophysiology, linking EdU-based assays to the latest immunometabolic research.

• LMO2-LDB1 Complex Drives AML Progression: Mechanisms and Ins

  2026-05-17

  This article analyzes the recent discovery of the LMO2/LDB1 complex’s essential role in the proliferation and survival of acute myeloid leukemia (AML) cells. The findings highlight the mechanistic importance of transcription factor interactions in leukemogenesis and suggest new molecular targets for therapeutic intervention.

• tFUS Damps Post-Stroke Neuroinflammation via Nespas/miR-383-

  2026-05-16

  This study demonstrates that transcranial focused ultrasound stimulation (tFUS) attenuates NLRP3-driven neuroinflammation following ischemic stroke by modulating the Nespas/miR-383-3p/SHP2 pathway. The findings reveal a mechanistic link between noninvasive neuromodulation and microglial inflammatory regulation, offering new molecular targets for post-stroke intervention.

• WY-14643 (Pirinixic Acid): Precision PPARα Agonist Workflows

  2026-05-15

  WY-14643 (Pirinixic Acid) is a benchmark tool for probing PPARα-mediated metabolic and regenerative signaling in preclinical models. This article bridges advanced experimental designs with practical troubleshooting, helping researchers leverage WY-14643 for metabolic disorder research, insulin sensitivity enhancement, and anti-inflammatory assays with data-driven confidence.

• TRPV1+ Nerve Stimulation Suppresses Inflammation via Reflex

  2026-05-15

  Song et al. (2025) revealed that targeted stimulation of TRPV1+ peripheral somatosensory nerves at the nape initiates a somato-autonomic reflex, rapidly suppressing systemic inflammation in murine models. This work uncovers specific neuro-immune circuitry and gene expression changes in the spleen, opening new avenues for translational research into inflammatory regulation.

• Pravastatin Sodium (A4369): Data-Driven Solutions for Cell A

  2026-05-14

  This article addresses real-world laboratory challenges faced in cell viability and cytotoxicity assays, providing evidence-based guidance on the use of Pravastatin sodium (SKU A4369). Through scenario-driven Q&A and rigorous protocol recommendations, researchers can achieve reproducible, quantitative results and confidently select APExBIO’s Pravastatin sodium for sensitive and reliable workflow performance.

• Human iPSC-Derived Sensory Neurons Enable HSV-1 Latency Mode

  2026-05-14

  This study establishes a robust, scalable system to model latent herpes simplex virus 1 (HSV-1) infection and reactivation using human sensory neurons differentiated from inducible pluripotent stem cells (hiPSCs). It provides a new human-relevant platform for investigating HSV latency mechanisms and evaluating therapeutic strategies beyond traditional animal models.

• Laminin (925-933): Mechanistic Leverage for Translational Re

  2026-05-13

  Explore how Laminin (925-933), a defined Laminin B1 chain peptide, enables advanced cell adhesion and migration assays, bridges ECM biology to translational disease models, and supports reproducibility in metastasis research. This thought-leadership article delivers mechanistic insight, strategic guidance, and practical protocol parameters for researchers seeking to elevate their experimental rigor and translational impact.

• Biomimetic Chromatography Advances Pulmonary Drug Permeabili

  2026-05-13

  This study evaluates biomimetic chromatographic techniques—immobilised artificial membrane liquid chromatography (IAM-LC) and open tubular capillary electrochromatography (OT-CEC)—for modeling lung permeability of pharmaceuticals. Findings demonstrate robust, MS-compatible workflows for high-throughput permeability assessment, with important implications for respiratory drug development.

• Olaparib (AZD2281): Workflow Advances in BRCA-Targeted Resea

  2026-05-12

  Olaparib (AZD2281) enables precise DNA damage response assays and innovative in situ drug delivery, propelling BRCA-associated cancer research and radiosensitization studies. Explore protocol enhancements, troubleshooting, and the latest nanotechnology-driven strategies with APExBIO’s rigorously characterized reagent.

16525 records 1/1102 page Next 12345 下5页 Last page